Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Investigative Radiology
|
December 3, 2021
Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly: An Analysis of 132,850 Patients From 4 Observational Studies and Pharmacovigilance Covering >288 Million Administrations
Jan Endrikat, Julia Chernova, Christoph Gerlinger, et al.
Journal of the American College of Cardiology
|
February 4, 2017
Mode of Death in Heart Failure With Preserved Ejection Fraction
Muthiah Vaduganathan, Ravi B Patel, Alexander Michel, et al.
Journal of Clinical Medicine
|
June 19, 2024
Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan
Suguru Okami, Christoph Ohlmeier, Makiko Takeichi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 4, 2024
Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany
Alexander Michel, Coralie Lecomte, Christoph Ohlmeier, et al.
Scientific Reports
|
April 20, 2024
Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan
Suguru Okami, Coralie Lecomte, Hanaya Raad, et al.
Scientific Reports
|
October 15, 2024
Author Correction: Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan
Suguru Okami, Coralie Lecomte, Hanaya Raad, et al.
European Journal of Heart Failure
|
December 5, 2015
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review
Muthiah Vaduganathan, Alexander Michel, Kathryn Hall, et al.
Open Heart
|
November 9, 2024
Epidemiology of myocarditis following COVID-19 or influenza and use of diagnostic assessments
Oisin Butler, Zahra Raisi-Estabragh, Yuchi Han, et al.
International Journal of Cardiology. Heart & Vasculature
|
March 20, 2026
One-year real-world outcomes after vericiguat initiation in heart failure: The ROVER-Japan cohort study
Makiko Takeichi, Shun Kohsaka, Kotaro Nochioka, et al.
European Journal of Clinical Pharmacology
|
March 13, 2024
Real-world characteristics and use patterns of patients treated with vericiguat: A nationwide longitudinal cohort study in Germany
Fabian Kerwagen, Christoph Ohlmeier, Thomas Evers, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Investigative Radiology
|
December 3, 2021
Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly: An Analysis of 132,850 Patients From 4 Observational Studies and Pharmacovigilance Covering >288 Million Administrations
Jan Endrikat, Julia Chernova, Christoph Gerlinger, et al.
Journal of the American College of Cardiology
|
February 4, 2017
Mode of Death in Heart Failure With Preserved Ejection Fraction
Muthiah Vaduganathan, Ravi B Patel, Alexander Michel, et al.
Journal of Clinical Medicine
|
June 19, 2024
Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan
Suguru Okami, Christoph Ohlmeier, Makiko Takeichi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 4, 2024
Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany
Alexander Michel, Coralie Lecomte, Christoph Ohlmeier, et al.
Scientific Reports
|
April 20, 2024
Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan
Suguru Okami, Coralie Lecomte, Hanaya Raad, et al.
Scientific Reports
|
October 15, 2024
Author Correction: Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan
Suguru Okami, Coralie Lecomte, Hanaya Raad, et al.
European Journal of Heart Failure
|
December 5, 2015
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review
Muthiah Vaduganathan, Alexander Michel, Kathryn Hall, et al.
Open Heart
|
November 9, 2024
Epidemiology of myocarditis following COVID-19 or influenza and use of diagnostic assessments
Oisin Butler, Zahra Raisi-Estabragh, Yuchi Han, et al.
International Journal of Cardiology. Heart & Vasculature
|
March 20, 2026
One-year real-world outcomes after vericiguat initiation in heart failure: The ROVER-Japan cohort study
Makiko Takeichi, Shun Kohsaka, Kotaro Nochioka, et al.
European Journal of Clinical Pharmacology
|
March 13, 2024
Real-world characteristics and use patterns of patients treated with vericiguat: A nationwide longitudinal cohort study in Germany
Fabian Kerwagen, Christoph Ohlmeier, Thomas Evers, et al.
Page
of 4